Increase of immune response and targeting by antigens and/or drug linkage
US8642565B2 · kind B2 · utility
1Cited by
22References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 7, 2008 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | Mar 31, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6018
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolipids and antigen. The said compounds are also able to target drug to CD1d restricted cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.